Clazakizumab (Anti-IL-6 Monoclonal) as an Agent to Reduce Donor Specific Hla Antibodies (DSA) and Improve Outcomes in Patients with Chronic & Active Antibody-Mediated Rejection Post-Kidney Transplantation (NCT03380377)

被引：0
|
作者：
Jordan, S. C. [1 ]
Ammerman, N. [1 ]
Toyoda, M. [1 ]
Ge, S. [1 ]
Huang, E. [1 ]
Peng, A. [1 ]
Sethi, S. [1 ]
Najjar, R. [1 ]
Ortiz, E. [1 ]
Chu, M. [1 ]
De Guzman, A. [1 ]
Kim, I. [1 ]
Lim, K. [1 ]
Choi, J. [1 ]
Vo, A. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2020年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B-63
引用
收藏
页码：848 / 849
页数：2
相关论文
共 25 条
  • [21] Effect of low-dose rituximab induction therapy for donor-specific Anti-HLA-Antibody (DSA) positive kidney transplant recipients: Marked reduction in DSA and antibody-mediated rejection after renal transplantation.
    Tanabe, Kazunari
    Ishida, Hideki
    Omoto, Kazuya
    Shimizu, Tomokazu
    Shirakawa, Hiroki
    Nishida, Hayato
    Tokumoto, Tadahiko
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 235 - 235
  • [22] Pre-transplant crossmatch-negative donor-specific anti-HLA antibody predicts acute antibody-mediated rejection but not long-term outcomes in kidney transplantation: an analysis of the Korean Organ Transplantation Registry
    Lee, Haeun
    Lee, Hanbi
    Sun, In O.
    Park, Jung Hwan
    Park, Jong-Won
    Ban, Tae Hyun
    Yang, Jaeseok
    Kim, Myoung Soo
    Yang, Chul Woo
    Chung, Byung Ha
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [23] Pre-transplant crossmatch-negative donor-specific anti-HLA antibody predicts acute antibody-mediated rejection but not long-term outcomes in kidney transplantation: an analysis of the Korean Organ Transplantation Registry (vol 15, 1420351, 2024)
    Lee, Haeun
    Lee, Hanbi
    Sun, In O.
    Park, Jung Hwan
    Park, Jong-Won
    Ban, Tae Hyun
    Yang, Jaeseok
    Kim, Myoung Soo
    Yang, Chul Woo
    Chung, Byung Ha
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [24] Pre- And Post-Transplant (Tx) Clazakizumab (CLZ, Humanized Anti-IL-6 Monoclonal Antibody) Treatment Increased Regulatory T Cell (Treg) Percentage in CD4+T Cells in HLA-Sensitized Kidney Transplant Patients (HS KTx Pts)
    Ge, S.
    Chu, M.
    Ortiz, E. D.
    Guzman, A. D.
    Vo, A.
    Ammerman, N.
    Jordan, S. C.
    Toyoda, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 902 - 903
  • [25] Tocilizmab (Anti-IL-6R) Treatment (TCZ-Rx) Reduced Total IgG Levels Including Anti-HLA IgG: Analysis of IgG Subclasses (IgG1-IgG4) and Anti-HLA IgG Subclasses Show Similar Reductions in All Subclasses from Patients with DSA plus Chronic Antibody-Mediated Rejection (CABMR)
    Shin, B. -H.
    Everly, M.
    Choi, J.
    Ge, S.
    Petrosyan, A.
    Vo, A.
    Jordan, S.
    Toyoda, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 537 - 537
123